Parkinson Research Consortium
Our research
We to bring together scientists with the common goals of understanding Parkinson’s disease and applying this knowledge to the treatment of those with the condition.
Parkinson's disease is the second most common neurodegenerative disease after Alzheimer's, affecting at least 100,000 Canadians, with the number of cases expected to double by the year 2050.
While the ultimate cause of Parkinson's disease is unknown, symptoms are mainly thought to result from the death of brain cells that produce a chemical called dopamine.
There are currently no proven treatments available to slow the relentless progression of the disease. Only through a better understanding of the basic mechanisms that cause it can effective disease-altering treatments be developed.
Recent Milestones in Parkinson's Disease Research
Enabling significant scientific progress by providing seed funding for novel research projects
Innovative ideas in research through support of multidisciplinary research teams
Publication of Canada's first Parkinson's care guideline and its revision in 2019.
Development of an Integrated Parkinson's Care Network driven by patients.
Development of a prediction tool model for Parkinson's disease.
Development of a simplified smell test.
Development of mouse models that mimic different forms of Parkinson's disease.
Participation and leadership in new drug treatment trials for Parkinson’s disease.
Continuous support of our next generation of young researchers.